Luke Timmerman and Team Kilimanjaro

Curing cancer one mountain at a time.

Biotech journalist Luke Timmerman and Team Kilimanjaro seek to raise $1 million for cancer research at Fred Hutch.

Event Details

Biotech Leaders Conquer Cancer

After Seattle writer and entrepreneur Luke Timmerman successfully summited Mt. Everest in 2018 to support Fred Hutch, he assembled extraordinary teams who summited Mt. Kilimanjaro in 2019 and trekked through the Himalayas to Everest Base Camp in 2022. Now, Luke and a team of executives and investors from the biotech and pharmaceutical industries are taking on Kilimanjaro again in February 2023.

Each Team Kilimanjaro climber will raise $50,000 or more to support cancer research at Fred Hutch.

To donate, select the name of the climber you would like to support or send your gift to the address below. Be sure to include the name of the climber you are supporting. For stock donations or wire transfer instructions, please email climb@fredhutch.org.

Fred Hutchinson Cancer Center
Attn: Climb to Fight Cancer
1100 Fairview Ave. N., Mail Stop J5-200
Seattle, WA 98109

Date:
February 2023
Host or Sponsor:
Fred Hutch
Location:
Mt. Kilimanjaro, Tanzania (19,431 feet)
Contact Information:

Meet the Team

  • Soufiane Aboulhouda, PhD candidate, Church Lab, Wyss Institute, Harvard University, co-founder and president, Nucleate
  • Ram Aiyar, CEO, Korro Bio
  • Jonathan Bricker, professor and director, Health and Behavioral Innovations in Technology Lab, Cancer Prevention Program, Fred Hutchinson Cancer Center
  • Joe Budman, vice president of biology, Vicinitas Therapeutics
  • Bharatt Chowrira, president, Puretech Health
  • Ginger Cooper, associate vice president, operations and commercialization strategy, Agilent Technologies
  • Jens Eckstein, managing partner, Apollo Health Ventures
  • Alex Federation, co-founder and CEO, Talus Bio
  • Saul Fink, SVP, pharmaceutical & nonclinical development, Normunity
  • Brian Gallagher Jr., biotech investor and entrepreneur
  • Laurie Halloran, founder and CEO, Halloran Consulting Group
  • Amber Kaplan, consultant, Amber Lab LLC, MBA candidate USC Marshall School of Business 
  • Nerissa Kreher, chief medical officer, Entrada Therapeutics
  • Jeff Leek, vice president, chief data officer, professor; Fred Hutchinson Cancer Center
  • Wendy Nelson, president and founder, Boston Biotech Forum; corporate development Danforth Advisors
  • Kamal Puri, CSO, OncoResponse
  • Andrew Sandford, president, Elevate Bio BaseCamp
  • Joanne Smith-Farrell, CEO, Be Biopharma
  • Luke Timmerman, founder and editor, Timmerman Report
  • Nathan Trinklein, co-founder and CSO, Rondo Therapeutics
  • Ramani Varanasi, managing director, ReVive Advisors
  • Ben Vollrath, COO, Amprion

2023 Sponsors

Trek Sponsor

OncoResponse logo

Team Timmerman Gallery

Last Modified, November 29, 2022